BPC-157 vs TB-500: Research Peptide Comparison

BPC-157 and TB-500 are two of the most referenced research peptides in tissue repair literature. This page compares how each compound is described in published research, summarises lot documentation practices at Amino Fuel Labs, and answers common questions investigators ask when sourcing either material for laboratory research.

Background on each compound

BPC-157 is a synthetic 15-amino-acid sequence derived from a gastric protein, widely cited in tissue and gastrointestinal research models. TB-500 is a synthetic fragment derived from thymosin beta-4, widely cited in soft tissue and cardiac research models. Both have generated significant research interest, and both are sold here for laboratory research only.

Reported research applications

Published research describes BPC-157 in tendon, soft tissue, and gut research models; TB-500 appears in soft tissue, cardiac, and dermal research models. Investigators frequently reference both peptides when designing tissue repair research and sometimes combine them in studies (the so-called Wolverine stack). Amino Fuel Labs makes no therapeutic claims.

Quality and purity documentation

Each lot of BPC-157 and TB-500 is verified by reverse-phase HPLC at a third-party analytical lab. The COA documents identity, lot number, manufacture and retest dates, appearance, and measured purity, with vial labels matching the COA lot for unambiguous tracking.

Selecting between them or stacking

Tendon and gut-focused research questions point investigators toward BPC-157; broader soft tissue and cardiac questions often point toward TB-500. Some investigators use the two together in research models; combined-use literature is referenced in the Wolverine stack research article. All material is sold for laboratory research only, not for human consumption.